Abstract
We used a degenerate RT-PCR screen and subsequent real-time quantitative RT-PCR assays to examine the expression of HOX and TALE-family genes in 34 cases of chromosomally defined AML for which outcome data were available. AMLs with favorable cytogenetic features were associated with low overall HOX gene expression whereas poor prognostic cases had high levels. Characteristically, multiple HOXA family members including HOXA3–HOXA10 were jointly overexpressed in conjunction with HOXB3, HOXB6, MEIS1 and PBX3. Higher levels of expression were also observed in the FAB subtype, AML-M1. Spearmann correlation coefficients indicated that the expression levels for many of these genes were highly inter-related. While we did not detect any significant correlations between HOX expression and complete response rates or age in this limited set of patients, there was a significant correlation between event-free survival and HOXA7 with a trend toward significance for HoxA9, HoxA4 and HoxA5. While patients with elevated HOX expression did worse, there were notable exceptions. Thus, although HOX overexpression and clinical resistance to chemotherapy often coincide, they are not inextricably linked. Our results indicate that quantitative HOX analysis has the potential to add new information to the management of patients with AML, especially where characteristic chromosomal alterations are lacking.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scott MP, Tamkun JW, Hartzell GW III . The structure and function of the homeodomain Biochim Biophys Acta 1989 989: 25–48
Graham A, Papalopulu N, Krumlauf R . The murine and Drosophila homeobox gene complexes have common features of organization and expression Cell 1989 57: 367–378
Flagiello D, Gibaud A, Dutrillaux B, Poupon MF, Malfoy B . Distinct patterns of all-trans retinoic acid dependent expression of HOXB and HOXC homeogenes in human embryonal and small-cell lung carcinoma cell lines FEBS Lett 1997 415: 263–267
Greer JM, Puetz J, Thomas KR, Capecchi MR . Maintenance of functional equivalence during paralogous Hox gene evolution Nature 2000 403: 661–665
Raza-Egilmez SZ, Jani-Sait SN, Grossi M, Higgins MJ, Shows TB, Aplan PD . NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia Cancer Res 1998 58: 4269–4273
Nakamura T, Yamazaki Y, Hatano Y, Miura I . NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15) Blood 1999 94: 741–747
Borrow J, Shearman AM, Stanton VP Jr, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE . The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9 Nat Genet 1996 12: 159–167
Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ . Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia Science 1991 253: 79–82
Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML . Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor Cell 1990 60: 535–545
Kamps MP, Murre C, Sun XH, Baltimore D . A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL Cell 1990 60: 547–555
Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, Largman C, Humphries RK . Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation Immunity 1997 6: 13–22
Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C, Humphries RK . Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia Mol Cell Biol 1997 17: 495–505
Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G . Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b EMBO J 1998 17: 3714–3725
Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S . Homeobox gene expression plus autocrine growth factor productionelicits myeloid leukemia Proc Natl Acad Sci USA 1990 87: 8398–8402
Joh T, Hosokawa Y, Suzuki R, Takahashi T, Seto M . Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells Oncogene 1999 18: 1125–1130
Rozovskaia T, Feinstein O, Foa R, Blechman J, Nakamura T, Croce CM, Cimino G, Canaani E . Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality Oncogene 2001 20: 874–878
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 1999 286: 531–537
Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, Rosell R, Gemmill RM, Drabkin HA . Altered HOX and WNT7A expression in human lung cancer Proc Natl Acad Sci USA 2000 97: 12776–12781
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, Rees JK, Stevens RF, Walker H . A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties Br J Haematol 1999 107: 69–79
Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Rowley JD . Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations N Engl J Med 1993 329: 909–914
Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrozek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD . Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry Leukemia 1998 12: 317–325
Bedford FK, Ashworth A, Enver T, Wiedemann LM . HEX: a novel homeobox gene expressed during haematopoiesis and conserved between mouse and human Nucleic Acids Res 1993 21: 1245–1249
Jayaraman PS, Frampton J, Goodwin G . The homeodomain protein PRH influences the differentiation of haematopoietic cells Leuk Res 2000 24: 1023–1031
Manfioletti G, Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH, Pinto A . Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells Blood 1995 85: 1237–1245
Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL . Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis Arch Gen Psychiatry 1987 44: 550–555
Hanley JA, McNeil BJ . A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 1983 148: 839–843
Magli MC, Barba P, Celetti A, De Vita G, Cillo C, Boncinelli E . Coordinate regulation of HOX genes in human hematopoietic cells Proc Natl Acad Sci USA 1991 88: 6348–6352
Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK . Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells Proc Natl Acad Sci USA 1994 91: 12223–12227
Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE . Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells Leukemia 1999 13: 687–698
Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C . Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells Exp Hematol 1995 23: 1160–1166
Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, Komuves L, Buchberg AM, Largman C . Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias Leukemia 1999 13: 1993–1999
Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, Knuutila S, Mrozek K, Oberkircher AR, Marcucci G, de la Chapelle A, Elonen E, Block AW, Rao PN, Herzig GP, Powell BL, Ruutu T, Schiffer CA, Bloomfield CD . Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics Cancer Res 1998 58: 55–59
Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G . Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia Mol Cell Biol 2001 21: 224–234
Schnabel CA, Jacobs Y, Cleary ML . HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis Oncogene 2000 19: 608–616
Buske C, Feuring-Buske M, Antonchuk J, Rosten P, Hogge DE, Eaves CJ, Humphries RK . Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo Blood 2001 97: 2286–2292
Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, Humphries RK . Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo Genes Dev 1995 9: 1753–1765
Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pattengale PK, Kohn DB, Gasson JC . Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors Blood 1999 94: 519–528
Nakamura T, Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG . Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias Nat Genet 1996 12: 149–153
Moskow JJ, Bullrich F, Huebner K, Daar IO, Buchberg AM . Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice Mol Cell Biol 1995 15: 5434–5443
Saleh M, Rambaldi I, Yang XJ, Featherstone MS . Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases Mol Cell Biol 2000 20: 8623–8633
Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C . Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia Cancer Res 2001 61: 2–7
Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C . HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells Mol Cell Biol 1999 19: 3051–3061
Shanmugam K, Green NC, Rambaldi I, Saragovi HU, Featherstone MS . PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins Mol Cell Biol 1999 19: 7577–7588
Mitelman F (ed). ISCN (1995): An International System for Human Cytogenetic Nomenclature S Karger: Basel 1995 Reference added in proof
Acknowledgements
We gratefully acknowledge the generous support from the Lulu Frankel Foundation. DNA sequencing support was provided by the University of Colorado Cancer Center DNA Sequencing Core. We also wish to acknowledge the generous support from L'Association pour la Recherche sur le Cancer (JR, AB, FB) and La Ligue Nationale Contre le Cancer, Comité de la Vienne et de Charente-Maritime (JR, AB, FB).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drabkin, H., Parsy, C., Ferguson, K. et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 16, 186–195 (2002). https://doi.org/10.1038/sj.leu.2402354
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402354
Keywords
This article is cited by
-
MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia
Clinical Epigenetics (2024)
-
Regulation of HOX gene expression in AML
Blood Cancer Journal (2024)
-
Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens
Nature Communications (2023)
-
Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches
Stem Cell Reviews and Reports (2022)
-
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
BMC Cancer (2020)